Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Clinical trial NCT04539236 · SUSPENDED
Trial details
- NCT number
- NCT04539236
- Sponsor
- Mikkael Sekeres, MD
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2029-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.